Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat

Adam J Chicco1, Genevieve C Sparagna, Sylvia A McCune

  • 1Department of Integrative Physiology, University of Colorado Cardiovascular Research Institute, University of Colorado, Boulder, USA. chicco@cahs.colostate.edu

Insights

High-fat diets impact heart disease prognosis differently based on fatty acid composition. Linoleate-rich diets may improve survival in advanced hypertensive heart disease, while lard-based diets hasten mortality.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Gerontology

Background:

  • High-fat diets may reduce cardiac hypertrophy and dysfunction in hypertension.
  • Prognostic effects of high-fat diets in aged individuals with advanced hypertensive heart disease remain unclear.
  • Fatty acid composition's role in modulating these effects requires investigation.

Purpose of the Study:

  • To investigate the impact of high-fat diet composition on disease progression and mortality in aged rats with advanced hypertensive heart failure.
  • To compare the effects of high-linoleate safflower oil and lard diets against a high-carbohydrate diet.

Main Methods:

  • Aged spontaneously hypertensive heart failure rats were fed either a high-carbohydrate diet, a high-fat diet with high-linoleate safflower oil, or a high-fat diet with lard until death.
  • Cardiac morphology, function, and mortality were assessed.
  • Myocardial fatty acid profiles, thromboxane excretion, and blood pressure were analyzed.

Main Results:

  • Both high-fat diets attenuated cardiac hypertrophy, left ventricular dilation, and systolic dysfunction compared to the high-carbohydrate diet.
  • The lard diet significantly increased mortality, while the linoleate diet significantly delayed mortality.
  • Linoleate-enriched diets increased myocardial cardiolipin content, a phospholipid deficient in failing hearts.

Conclusions:

  • Dietary fatty acid composition critically influences mortality in advanced hypertensive heart disease, despite potential benefits on cardiac structure and function.
  • Linoleate-rich diets may offer a survival advantage, potentially via cardiolipin enrichment.
  • Further research is needed to elucidate the mechanisms behind these divergent effects.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...